Emerging Agents in Small Cell Lung Cancer

Episode
210
Soundcloud
Share

Small cell lung cancer is a challenging subtype of lung cancer to treat because most patients present with extensive stage disease. Unlike non-small cell lung cancer, treatments are more limited. Fortunately, the field continues to advance, and several novel agents are showing promise. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses some of these promising therapies with Dr. Anne Chiang and Dr. Luis Paz-Ares.

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Dr. Anne Chiang
Anne Chiang

MD

Associate Professor and the Associate Cancer Center Director for Clinical Initiatives at the Yale Cancer Center
Yale School of Medicine
Luis Paz-Ares
Luis Paz-Ares

MD

Head of Medical Oncology
Hospital Universitario 12 Dothe de Octubre
Head of the Lung Cancer Unit at the CNIO